Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 3Urinary Bladder Neoplasms 1Tobacco Use Disorder 1Sunburn 1Stress, Psychological 1Stress Disorders, Post-Traumatic 1Smoking Cessation 1Prostatic Hyperplasia 1Motor Activity 1Melanoma 1Head and Neck Neoplasms 1Depression 1Anxiety Disorders 1Alzheimer Disease 1Acquired Immunodeficiency Syndrome 1

Interventions

Dexamethasone 4XENP 1595 2Electroencephalography 2selinexor 1pomalidomide 1ixazomib 1fasudil 1birtamimab 1UE2343 1Telemedicine 1Tablets 1Standard of Care 1Rosiglitazone 1Propofol 1Positron-Emission Tomography 1Methods 1Melphalan 1Mass Screening 1Magnetic Resonance Imaging 1Lysine Acetyltransferase 5 1Hypnosis 1Hormones 1Exercise 1Ethanol 1Donepezil 1Cyclophosphamide 1Control Groups 1Calcium Dobesilate 1Bortezomib 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Alzheimer Disease × Amyloid × Clear all
NCT02939612 2025-03-20

Stress Management Intervention in Early Stage Cancer: Randomized Controlled Trial

Oslo University Hospital

Phase NA Active not recruiting
200 enrolled

Alzheimer Disease, Neoplasms, Stress, Psychological

Data powered by HemOnc (CC BY 4.0) Colophon âš¡